Literature DB >> 5086002

Axillary lymph node dissection for melanoma.

M N Harris, S L Gumport, H Maiwandi.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 5086002

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  8 in total

1.  The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial.

Authors:  R G Somers; L K Jablon; M J Kaplan; G L Sandler; N K Rosenblatt
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

2.  Melanoma of the head and neck.

Authors:  M N Harris; D F Roses; A T Culliford; S L Gumport
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

3.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast.

Authors:  D F Roses; A D Brooks; M N Harris; R L Shapiro; J Mitnick
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Results of regional lymph node dissection for melanoma.

Authors:  S L Gumport; M N Harris
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

5.  Isolated regional lymph node dissection: morbidity, mortality and economic considerations.

Authors:  K I Bland; T W Klamer; H C Polk; C O Knutson
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

6.  Total mastectomy with complete axillary dissection.

Authors:  D F Roses; M N Harris; D A Potter; S L Gumport
Journal:  Ann Surg       Date:  1981-07       Impact factor: 12.969

7.  Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition.

Authors:  Emma C Starritt; David Joseph; J Gregory McKinnon; Sing Kai Lo; Johannes H W de Wilt; John F Thompson
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

8.  Cutaneous melanoma of the breast.

Authors:  D F Roses; M N Harris; J S Stern; S L Gumport
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.